Under the leadership of Vasant Narasimhan, Novartis has reported a rise in sales and operating profit in the first quarter and completed two commercial transactions that will shape the company’s pharmaceutical portfolio in the months to come. ---Subscribe to MedNous to access this article--- Company News
